Tyra Biosciences Inc. (TYRA)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
RA Capital Management

Peter Kolchinsky

10,637,290 $147,858,331 +3% 1.96%
2. 3,944,194 $54,824,297 -16% 1.85%
3.
Boxer Capital

Aaron Davis And Christopher Fuglesang

2,027,678 $28,184,724 2.39%
4.
OrbiMed Advisors

Samuel Isaly

1,470,086 $20,434,195 +92% 0.42%
5.
Farallon Capital

Thomas Steyer

1,000,981 $13,913,636 0.07%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$16.25 1,220,681 8,697,956 2024-11-08 Filing
$16.00 9,500 12,849 2024-10-30 Filing
$13.12 125,000 Large Shareholder 6,448,359 2021-12-17 Filing
$16.00 312,500 Other 1,069,932 2021-09-17 Filing
$16.00 156,250 Director 4,080,296 2021-09-17 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$13.76 3,511 443,885 2025-02-05 Filing
$13.76 1,890 3,700,705 2025-02-05 Filing
$16.26 4,825 3,702,595 2025-01-23 Filing
$16.36 3,993 3,707,420 2025-01-21 Filing
$16.40 461 447,396 2025-01-17 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 4,179,857 $58,100,012 75.17%
2. 4,080,296 $56,716,114 89.47%
3. 4,055,861 $56,376,468 9.14%
4. 3,107,970 $43,200,783 0%
5. 1,989,103 $27,648,532 2.7%
News See All